Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$754
|
$708B |
14.4x |
36.9x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$154
|
$384B |
4.3x |
12.1x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$179
|
$378B |
6.6x |
14.7x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$79
|
$223B |
3.5x |
8.2x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$294
|
$206B |
6.1x |
10.5x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$169B |
2.7x |
7.0x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$106
|
$148B |
5.1x |
12.4x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$145B |
3.0x |
14.9x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$496
|
$123B |
10.9x |
56.9x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$151
|
$72.0B |
7.8x |
18.2x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$22.3B |
1.5x |
5.0x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$119
|
$21.7B |
2.3x |
6.5x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$32
|
$19.8B |
6.9x |
7.5x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$11.1B |
1.7x |
5.7x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$95
|
$8.8B |
3.6x |
12.8x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$61
|
$8.5B |
8.0x |
12.6x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$21
|
$4.9B |
11.1x |
27.1x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$4.7B |
1.7x |
7.4x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$28
|
$3.9B |
2.6x |
9.7x |
Endo
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$22
|
$3.8B |
N/A |
N/A |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$3.7B |
6.9x |
25.3x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$29
|
$2.4B |
311.6x |
-9.3x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$18
|
$2.1B |
N/A |
N/A |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$69
|
$2.0B |
3.0x |
11.9x |
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$49
|
$1.8B |
7.8x |
-17.3x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$20
|
$1.8B |
15.1x |
-28.4x |
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$59
|
$1.7B |
364.5x |
N/A |
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$24
|
$1.6B |
2.2x |
5.6x |
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$27
|
$1.6B |
2.3x |
3.8x |
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$1.4B |
6.2x |
-12.4x |
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$1.3B |
5.0x |
-7.6x |
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$32
|
$1.3B |
2.1x |
8.4x |
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$1.3B |
2.7x |
-76.2x |
OPKO Health
|
United States of America |
Biopharmaceuticals,
Medical Imaging & Diagnostics
|
$1
|
$1.2B |
1.7x |
-12.3x |
Innoviva
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$18
|
$1.2B |
3.2x |
N/A |
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$24
|
$1.1B |
4.7x |
19.9x |
Nika Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$1.0B |
N/A |
N/A |
Ardelyx
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$993M |
2.9x |
-87.6x |
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$969M |
26.0x |
N/A |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$960M |
3.3x |
22.4x |
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$40
|
$932M |
N/A |
-6.0x |
Xeris Biopharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$4
|
$840M |
3.9x |
85.3x |
Emergent BioSolutions
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$813M |
0.8x |
4.5x |
Aurinia Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$783M |
3.2x |
N/A |
Syndax
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$730M |
17.7x |
-2.2x |
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$705M |
N/A |
-3.5x |
Oculis Holding
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$704M |
774.1x |
-7.1x |
Avadel Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$675M |
3.5x |
-151.4x |
WAVE Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$644M |
6.6x |
-4.8x |
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$630M |
N/A |
-3.0x |
Anavex Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$629M |
N/A |
N/A |
Ironwood Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$616M |
1.8x |
6.2x |
Sionna Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$586M |
N/A |
-7.1x |
Zymeworks
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$558M |
6.8x |
-4.2x |
Enliven Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$551M |
267976.7x |
-4.9x |
Arbutus Biopharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$3
|
$507M |
81.7x |
N/A |
Akebia Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$2
|
$474M |
2.8x |
N/A |
89bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$462M |
N/A |
-1.3x |
Elite Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$0
|
$457M |
N/A |
N/A |
LENZ Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$432M |
198.7x |
-6.6x |
ArriVent BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$18
|
$407M |
N/A |
-4.6x |
UroGen Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$375M |
3.8x |
-3.7x |
Pharvaris
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$370M |
N/A |
-2.2x |
Xencor
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$364M |
3.3x |
-2.0x |
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$362M |
N/A |
-1.7x |
Esperion Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$351M |
1.0x |
7.0x |
Sana Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$349M |
N/A |
-1.5x |
Savara
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$3
|
$331M |
N/A |
N/A |
Dianthus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$19
|
$327M |
60.0x |
N/A |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$0
|
$324M |
N/A |
N/A |
Alpha Teknova
|
United States of America |
Contract Research & Manufacturing,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$303M |
7.9x |
-21.7x |
SIGA Technologies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$284M |
2.1x |
4.3x |
CytoDyn
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$0
|
$259M |
N/A |
N/A |
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$10
|
$232M |
N/A |
-1.9x |
Phathom Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$227M |
2.6x |
-0.9x |
Altimmune
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$226M |
15022.3x |
-2.1x |
Wellgistics Health
|
United States of America |
Medical Devices,
Biopharmaceuticals
|
$4
|
$223M |
N/A |
N/A |
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$30
|
$209M |
32.0x |
-1.0x |
Day One Biopharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$203M |
1.4x |
-1.0x |
Maze Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Digital Therapeutics
|
$8
|
$202M |
1.7x |
37.1x |
OmniAb
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$199M |
7.8x |
-4.6x |
Stoke Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$194M |
4.5x |
-2.1x |
Nuvation Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$192M |
12.6x |
N/A |
Protalix
|
United States of America |
Biopharmaceuticals
|
$3
|
$175M |
2.8x |
N/A |
Mind Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$166M |
N/A |
-1.5x |
Regenxbio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$165M |
1.1x |
-1.2x |
Armata Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$159M |
30.2x |
-3.6x |
Y-mAbs Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$157M |
1.8x |
-5.0x |
Aura Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$141M |
N/A |
N/A |
Bicara Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$132M |
N/A |
-1.5x |
Tyra Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$112M |
N/A |
-1.0x |
ORIC Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$110M |
N/A |
-0.7x |
Erasca
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$105M |
N/A |
-0.6x |
Tourmaline Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$104M |
N/A |
N/A |
Aardvark Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$92.4M |
N/A |
-3.1x |
Prothena Corp.
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$10
|
$74.5M |
0.7x |
N/A |
Arcturus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$10
|
$67.6M |
0.5x |
-0.6x |
Lexicon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$62.0M |
2.5x |
-0.4x |
ImmuCell
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Agriculture
|
$5
|
$60.7M |
N/A |
N/A |
Cullinan Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$56.1M |
17.7x |
-0.3x |